The University of Chicago Header Logo

Connection

Mark Talamonti to Cholangiocarcinoma

Back to Details
This is a "connection" page, showing publications Mark Talamonti has written about Cholangiocarcinoma.
Mark Talamonti
Connection Strength
0.590
Cholangiocarcinoma
  1. Endovascular management of portal vein obstruction in hepatobiliary cancer patients. J Surg Oncol. 2022 Mar; 125(3):392-398.
    View in: PubMed
    Score: 0.194
  2. Clinical features of primary and metastatic hepatic malignancies. Cancer Treat Res. 2001; 109:1-14.
    View in: PubMed
    Score: 0.184
  3. Defining the Benefit of Adjuvant Therapy Following Resection for Intrahepatic Cholangiocarcinoma. Ann Surg Oncol. 2015 Jul; 22(7):2209-17.
    View in: PubMed
    Score: 0.121
  4. Survival outcomes in resected extrahepatic cholangiocarcinoma: effect of adjuvant radiotherapy in a surveillance, epidemiology, and end results analysis. Int J Radiat Oncol Biol Phys. 2011 Sep 01; 81(1):189-98.
    View in: PubMed
    Score: 0.091
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.